Mechanisms promoting escape from mitotic stress-induced tumor cell death

Rebecca Sinnott1, Leah Winters2, Brittany Larson3

  • 1Authors' Affiliations: Department of Pharmacology and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill;

Cancer Research
|May 27, 2014
PubMed

Insights

Intrinsic paclitaxel resistance in non-small cell lung cancer (NSCLC) stems from a failure to trigger apoptosis after mitotic defects. Targeting this resistance mechanism could enhance chemotherapy effectiveness for NSCLC patients.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Non-small cell lung cancer (NSCLC) exhibits poor responses to initial treatments.
  • Intrinsic chemoresistance in NSCLC, unlike acquired resistance, is poorly understood.
  • Paclitaxel resistance in NSCLC is linked to a cell-autonomous mechanism where mitotic defects do not induce apoptosis.

Purpose of the Study:

  • To investigate the molecular basis of intrinsic paclitaxel resistance in NSCLC.
  • To identify factors that enable cancer cells to evade apoptosis despite mitotic stress.
  • To explore therapeutic strategies to overcome paclitaxel resistance in NSCLC.

Main Methods:

  • Genome-wide RNAi screen combined with high-throughput toxicity and live-cell imaging.
  • Utilized a small molecule inhibitor of the APC/cyclosome to prolong mitotic arrest.
  • Investigated the roles of CASC1 and TRIM69 in resistance to spindle poisons.

Main Results:

  • Prolonging mitotic arrest sensitized paclitaxel-resistant NSCLC cells.
  • Identified CASC1 and TRIM69 as novel contributors to resistance against spindle poisons.
  • CASC1 is crucial for microtubule polymerization and spindle assembly checkpoint function.
  • TRIM69 is essential for bipolar spindle formation by associating with spindle poles and promoting centrosomal clustering.
  • RNAi-mediated reduction of CASC1 or TRIM69 inhibited tumor growth in vivo.

Conclusions:

  • Intrinsic paclitaxel resistance in NSCLC is mediated by a permissive mitotic checkpoint that allows survival despite chromosomal instability.
  • CASC1 and TRIM69 play critical roles in this resistance mechanism.
  • Targeting this adaptation by restoring apoptotic responses to mitotic damage offers a potential strategy for treating drug-resistant NSCLC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
8.5K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
2.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K